PGE2 receptor agonists (Merck Serono)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePGE2 receptor agonists (Merck Serono)
Drug Alias NamePGE2 receptor agonists (Serono)AS-02
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin E2 agonists
TargetsProstaglandin E2
Therapy Area/IndicationsInflammationInfertilityRespiratory Tract Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Serono Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono Sa
Active IndicationsN/A
Inactive IndicationsInflammationInfertilityRespiratory Tract Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A